Businesswire News Releases

Apr 29, 2024 08:24 ET
Cordless Power Tools Global Market Forecast Report 2023-2028: Rising Demand for Industrial Heat Guns and Increased Prominence of Asian Manufacturing - ResearchAndMarkets.com
The "Global Cordless Power Tools Market - Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering....
Apr 29, 2024 08:11 ET
The Cheesecake Factory Celebrates Moms With Sweet Online Gift Card Offer
The Cheesecake Factory® (NASDAQ: CAKE), known for its extensive menu, generous portions and legendary desserts, is making Mother’s Day shopping sweeter with a special online gift card offer: For every $50 in Gift Cards
Apr 29, 2024 08:08 ET
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement
MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent director Stan V. Smith, Ph.D. made an individual purchase of 147,492 shares, and warrants for 147,492 shares, of MAIA’s common stock as part of the Company’s recent private placement of common stock and warrants....
Apr 29, 2024 08:00 ET
Aspen Technology Appoints David Henshall to its Board of Directors
Aspen Technology, Inc. (NASDAQ: AZPN), a global leader in industrial software, today announced that David Henshall has been appointed to its Board of Directors....
Apr 29, 2024 08:00 ET
Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Eptifibatide for Injection in the United States as a therapeutic equivalent generic for Integrilin® for Injection (Eptifibatide) approved by the U.S. Food and Drug Administration. Eptifibatide for Injection is indicated for use in acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI)....
Apr 29, 2024 08:00 ET
Cognito Therapeutics Announces Presentation at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2024 Meeting
Cognito Therapeutics, a leader in technology-based therapeutic interventions for neurodegenerative diseases, announced today a poster presentation at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2024 Meeting, held May 5-8 in Atlanta, GA. The presented research is a targeted literature review of the clinical, hum...
Apr 29, 2024 08:00 ET
Dermavant Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that the U.S. Food and Drug Administration (FDA) accepted the company’s Supplemental New Drug Application (sNDA) for VTAMA® (tapinarof) cream, 1% for the topical treatment of atopic dermatitis (AD) in adults and children 2 years of age and older. The Prescription Drug User Fee Act ("PDUFA") action date assigned by the Agency is in Q4 2024....
Apr 29, 2024 08:00 ET
Franklin Templeton Fund Adviser, LLC Announces Distributions for the Month of May 2024
Franklin Templeton Fund Adviser, LLC announced today that certain closed end funds have declared their distributions for the month of May 2024....
Apr 29, 2024 08:00 ET
Keysight Announces Date of Second Quarter 2024 Financial Results Conference Call
Keysight Technologies, Inc. (NYSE: KEYS) will release financial results for the fiscal quarter ending April 30, 2024 after the close of the market on Monday, May 20, 2024. The company will host a conference call that day at 1:30 p.m. PT (4:30 p.m. ET) to review the financial results....
Apr 29, 2024 08:00 ET
LVXP Announces Plans to Deliver Experiential Mixed-Use Development Anchored by Entertainment and Sports Arena on Las Vegas Strip
Real estate development company LVXP has announced plans to deliver a new experiential mixed-use development on the Las Vegas Strip that will be anchored by a technologically advanced entertainment and sports arena. The transformational project will be located on the 27-acre site at 2601 South Las Vegas Boulevard....
Apr 29, 2024 08:00 ET
Modern Health Welcomes Dr. Reena Pande and Dr. Samantha Meltzer-Brody As Clinical Advisors
Modern Health, a leading global workplace mental health platform, today announces the appointment of
Apr 29, 2024 08:00 ET
NCR Voyix to Release First Quarter 2024 Earnings Results on May 9, 2024
NCR Voyix Corporation (NYSE: VYX), a leading global provider of digital commerce solutions, announced it will report consolidated financial results for the first quarter of 2024 before the market opens on May 9, 2024. Management will host a conference call to discuss the Company’s financial results at 8:00 a.m. ET on Thursday, May 9, 2024....
Apr 29, 2024 08:00 ET
Ole Smoky Distillery Earns Seven ‘Growth Brand’ Awards From Beverage Information Group
Ole Smoky Distillery, one of the nation’s fastest growing spirits companies, has been nationally recognized with seven prestigious 2024 Growth Brand Awards from the Beverage Information Group, leaders in the beverage alcohol data collection, reporting and analysis, and publishers of
Apr 29, 2024 08:00 ET
onsemi First Quarter 2024 Results Exceed Expectations
onsemi (the “Company”) (Nasdaq: ON) today announced results for the first quarter of 2024 with the following highlights:...
Apr 29, 2024 08:00 ET
Redfin Reports Nearly 1 in 5 People Who Plan To Vote for Trump Want to Live in a Place Where Abortion Is Legal
(NASDAQ: RDFN) —Nearly one of every five (17.6%) U.S. homeowners and renters who plan to vote for Donald Trump in the upcoming presidential election want to live in a place where abortion is legal. That’s according to a new report from Redfin (
Apr 29, 2024 08:00 ET
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced the appointment of Thomas (Tommy) Leggett as Chief Financial Officer. In this role, Mr. Leggett will be responsible for overse...
Apr 29, 2024 08:00 ET
Western Asset High Yield Defined Opportunity Fund Inc. Announces Financial Position as of February 29, 2024
Western Asset High Yield Defined Opportunity Fund Inc. (NYSE: HYI) today announced the financial position of the Fund as of February 29, 2024....
Apr 29, 2024 08:00 ET
Western Asset Intermediate Muni Fund Inc. Announces Financial Position as of February 29, 2024
Western Asset Intermediate Muni Fund Inc. (NYSE: SBI) today announced the financial position of the Fund as of February 29, 2024....
Apr 29, 2024 08:00 ET
Western Asset Managed Municipals Fund Inc. Announces Financial Position as of February 29, 2024
Western Asset Managed Municipals Fund Inc. (NYSE: MMU) today announced the financial position of the Fund as of February 29, 2024....
Apr 29, 2024 08:00 ET
ZEDEDA to Present on Open Source Software and Security at the Edge at ONE Summit
ZEDEDA, the leader in edge management and orchestration, today announced its plans for the Open Networking and Edge Summit (ONE Summit), which will be held from April 29 to May 1 in San Jose, California....